2,620 Astera Labs, Inc. $ALAB Shares Sold by Left Brain Wealth Management LLC

Left Brain Wealth Management LLC trimmed its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 58.6% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,848 shares of the company’s stock after selling 2,620 shares during the period. Left Brain Wealth Management LLC’s holdings in Astera Labs were worth $658,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Amazon Com Inc. bought a new stake in shares of Astera Labs in the second quarter valued at approximately $134,172,000. Edgestream Partners L.P. bought a new stake in Astera Labs in the 1st quarter valued at $1,891,000. Lido Advisors LLC boosted its holdings in Astera Labs by 123.4% in the 1st quarter. Lido Advisors LLC now owns 27,477 shares of the company’s stock valued at $3,012,000 after purchasing an additional 15,180 shares during the period. Strs Ohio grew its position in Astera Labs by 996.3% in the 1st quarter. Strs Ohio now owns 33,086 shares of the company’s stock worth $3,626,000 after purchasing an additional 30,068 shares during the last quarter. Finally, Silvant Capital Management LLC acquired a new stake in Astera Labs in the 2nd quarter worth $11,277,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 408,558 shares of company stock valued at $127,306,034. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $258.70 on Friday. The firm has a market cap of $44.88 billion, a P/E ratio of 187.37 and a beta of 3.68. The firm’s 50-day simple moving average is $308.12 and its 200-day simple moving average is $254.98. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Royal Bank Of Canada upped their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Barclays lifted their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Jefferies Financial Group boosted their price target on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Weiss Ratings lowered Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. Finally, Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Eleven investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $340.79.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.